Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7085 in Ulcerative Colitis
NCT07229950Phase 2Recruiting
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Oct 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7085 in ulcerative colitis (UC), sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Oct 2025; status: recruiting.
02
Drugs
HRS-7085
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07229950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07229950.